Susquehanna International Group
CABA icon

Susquehanna International Group’s Cabaletta Bio CABA Stock Holding History

Susquehanna International Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Sell
37,200
-49,100
-57% -$136K ﹤0.01% 12344
2025
Q4 		$189K Buy
86,300
+71,400
+479% +$177K ﹤0.01% 10941
2025
Q3 		$34.9K Sell
14,900
-47,200
-76% -$81K ﹤0.01% 11952
2025
Q2 		$94.4K Buy
62,100
+4,100
+7% +$6.39K ﹤0.01% 11831
2025
Q1 		$80.6K Buy
58,000
+27,400
+90% +$58.4K ﹤0.01% 11670
2024
Q4 		$69.5K Sell
30,600
-41,200
-57% -$145K ﹤0.01% 11543
2024
Q3 		$339K Buy
71,800
+52,500
+272% +$304K ﹤0.01% 9330
2024
Q2 		$144K Sell
19,300
-14,500
-43% -$178K ﹤0.01% 10727
2024
Q1 		$577K Buy
33,800
+10,900
+48% +$234K ﹤0.01% 8163
2023
Q4 		$520K Sell
22,900
-14,000
-38% -$235K ﹤0.01% 8578
2023
Q3 		$562K Buy
36,900
+8,600
+30% +$118K ﹤0.01% 7960
2023
Q2 		$365K Buy
+28,300
New +$307K ﹤0.01% 9037
2022
Q2 		– Sell
-13,600
Closed -$28K – 12946
2022
Q1 		$28K Sell
13,600
-42,300
-76% -$111K ﹤0.01% 12528
2021
Q4 		$212K Buy
55,900
+25,100
+81% +$268K ﹤0.01% 11320
2021
Q3 		$375K Sell
30,800
-9,200
-23% -$84.8K ﹤0.01% 10077
2021
Q2 		$344K Buy
+40,000
New +$393K ﹤0.01% 10476

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group's CABA Position: Q1 2026 in Review

Susquehanna International Group sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 138,281 shares — an estimated $384K sold.

Susquehanna International Group first reported a position in CABA in Q4 2019 and held it in 19 quarters. The position peaked at $2.19M in Q1 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Susquehanna International Group reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 138,281 Cabaletta Bio shares in Q1 2026, an estimated $384K.
  • Susquehanna International Group first reported a position in Cabaletta Bio in Q4 2019 and held it in 19 quarters.
  • Susquehanna International Group's Cabaletta Bio position peaked at $2.19M in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.